{"url_path":"/sec/limnw/8-k/2026-06-03/item-3-03","section_key":"item-3-03","section_title":"Item 3.03 Material Modification to Rights","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-26-070173-index.html","accession_number":"0001104659-26-070173","cik":"0001971387","ticker":"LIMN","issuer_name":"Liminatus Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-26-070173-index.html","primary_entity_key":"0001971387","primary_entity_name":"Liminatus Pharma, Inc."},"word_count":33,"has_tables":true,"body_markdown":"Item 3.03 Material Modification to Rights\nof Security Holders.\n\n \n\nTo the extent required, the information included\nin Item 1.01 of this Current Report is hereby incorporated by reference into this Item 3.03.\n\n \n\n2"}